Blood thinning technique for bone tumor surgery
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests a technique called 'acute normovolemic hemodilution' during bone tumor surgery. It involves temporarily thinning your blood by removing some red blood cells and replacing them with fluid, which may reduce the need for blood transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are scheduled for a non-urgent bone tumor removal surgery that is not minimally invasive.
- Your hemoglobin level is 11 g/dL or higher (meaning you have enough red blood cells).
- You are not using a tourniquet during surgery.
- You have no active infections, serious heart or lung problems, or liver/kidney issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a technique that thins your blood during surgery can help people having bone tumor removal. It may reduce the need for blood transfusions.
This trial tests a technique called acute normovolemic hemodilution (ANH) during bone cancer surgery. ANH involves removing some blood before surgery and replacing it with fluids, then giving the blood back after surgery to reduce the need for donor blood transfusions.
This trial is testing a special fluid called succinylated gelatin (a type of colloid) given during surgery to help maintain blood volume. It is for people having planned surgery lasting less than 6 hours and who are in generally good health, without major heart, liver, or kidney problems.
This study looks at a customized blood-pressure and fluid strategy to help patients during laparoscopic liver tumor removal. It may help reduce complications related to blood loss and organ stress during surgery.
This trial tests if removing some blood before surgery and replacing it with fluids can reduce the need for transfusions in people with advanced ovarian cancer. It may help you have less blood loss during your operation.
This trial tests a combination of medications (intravenous iron, EPO, and tranexamic acid) given before surgery to help manage anemia or iron deficiency in people with bone tumors. The goal is to improve blood counts and reduce the need for transfusions during recovery.
Hear when a new Bone Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.